My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2020-241A
CBCC
>
Official Documents
>
2020's
>
2020
>
2020-241A
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/5/2021 2:03:08 PM
Creation date
12/7/2020 1:21:53 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Addendum
Approved Date
11/17/2020
Control Number
2020-241A
Agenda Item Number
8.H.
Entity Name
RxBenefits, Inc. f/k/a Prescription Benefits, Inc.
Subject
Addendum to administrative services agreement (originals w/ Suzanne Boyll)
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
48
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
REBATES <br />14. Rebate revenue will not have any impact on discount guarantee reporting and/or true up. <br />15. Rebates will be paid for brand Prescription Drug Claims and at a flat minimum dollar -for -dollar guarantee <br />basis <br />16. Contract rebate guarantees are not subject to change as a result of known brand patent expirations. <br />17. The rebate guarantees are not subject to formulary percentage criteria. <br />DATA <br />18. Audit files will be supplied to Client and Client's consultant directly from the source system and should include <br />all Prescription Drug Claims processed including, but not limited to, paid, reversed and denied Prescription <br />Drug Claims. <br />19. ESI will provide the above mentioned extract at no charge to Client. <br />20. At no charge, ESI must be able to transfer data to Client's other vendor partners (e.g., medical plan <br />administrator, stop loss vendor, disease management vendor, catastrophic claimant advocate, etc.), with an <br />appropriate non -disclosure agreement in place. <br />21. ESI can provide the fully identified NCPDP expanded format to Client's consultant on a monthly basis at no <br />additional charge for use by both the InfoLock team and the Pharmacy Analytics Team. <br />22. InfoLock Data feeds that are in place will be honored even after termination at no cost to Client or Client's <br />consultant. In other words, if the Agreement is not renewed following the Term, InfoLock must still receive <br />the 4th quarter data even though it will not be available until after termination of this Agreement. <br />AUDITS <br />23. Third Party Audits- Client may employ a third party auditor, at Client's sole cost and expense, to conduct <br />audits of the terms of this Exhibit A, including, but not limited to: <br />• Pharmacy Claims transactions <br />• Financial performance guarantees <br />24. Client's consultant (Lockton) may perform a pre -implementation audit prior to the Effective Date. <br />MISCELLANEOUS <br />25. Any costs bidding entities may incur as it relates to attending meetings, site visits or negotiations are the <br />responsibility of Administrator. <br />26. Client will not be responsible for any unpaid Member co -payment or co-insurance amounts. <br />27. Client may not terminate this Agreement without cause and may only terminate this Agreement as expressly <br />provided for in Article VI of the Agreement. <br />28. If this Agreement is terminated prior to the completion of a Contract Year, the financial guarantees associated <br />with that partial Contract Year will still apply and be reconciled accordingly. <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />15 <br />
The URL can be used to link to this page
Your browser does not support the video tag.